Herpes Zoster after mRNA COVID-19 Vaccination: A Case Series
We present seven immunocompetent patients devoid of any comorbidities and risk factors, who developed for the first time in their life varicella-zoster virus (VZV) reactivation shortly after 1st (four patients) and 2nd dose (three patients) of mRNA COVID-19 vaccines.All four patients who exhibited herpes zoster after the 1st dose of vaccine received the 2nd dose without any adverse reactions or complications. Oral treatment prescribed to all patients with valacyclovir (Valtrex 1 mg tds/day) for 5-7 days led to a complete resolution of symptoms, and rashes disappeared within 9-14 days. Presently, All patients have completed...
Source: Skinmed - August 17, 2022 Category: Dermatology Authors: Alexandra Monastirli Efstathia Pasmatzi George Badavanis Gianna Panagiotopoulou Assimina Apostolidou Dionysios Tsambaos Source Type: research
Herpes Zoster after mRNA COVID-19 Vaccination: A Case Series
We present seven immunocompetent patients devoid of any comorbidities and risk factors, who developed for the first time in their life varicella-zoster virus (VZV) reactivation shortly after 1st (four patients) and 2nd dose (three patients) of mRNA COVID-19 vaccines.All four patients who exhibited herpes zoster after the 1st dose of vaccine received the 2nd dose without any adverse reactions or complications. Oral treatment prescribed to all patients with valacyclovir (Valtrex 1 mg tds/day) for 5-7 days led to a complete resolution of symptoms, and rashes disappeared within 9-14 days. Presently, All patients have completed...
Source: Skinmed - August 17, 2022 Category: Dermatology Authors: Alexandra Monastirli Efstathia Pasmatzi George Badavanis Gianna Panagiotopoulou Assimina Apostolidou Dionysios Tsambaos Source Type: research
Herpes Zoster after mRNA COVID-19 Vaccination: A Case Series
We present seven immunocompetent patients devoid of any comorbidities and risk factors, who developed for the first time in their life varicella-zoster virus (VZV) reactivation shortly after 1st (four patients) and 2nd dose (three patients) of mRNA COVID-19 vaccines.All four patients who exhibited herpes zoster after the 1st dose of vaccine received the 2nd dose without any adverse reactions or complications. Oral treatment prescribed to all patients with valacyclovir (Valtrex 1 mg tds/day) for 5-7 days led to a complete resolution of symptoms, and rashes disappeared within 9-14 days. Presently, All patients have completed...
Source: Skinmed - August 17, 2022 Category: Dermatology Authors: Alexandra Monastirli Efstathia Pasmatzi George Badavanis Gianna Panagiotopoulou Assimina Apostolidou Dionysios Tsambaos Source Type: research
Herpes Zoster after mRNA COVID-19 Vaccination: A Case Series
We present seven immunocompetent patients devoid of any comorbidities and risk factors, who developed for the first time in their life varicella-zoster virus (VZV) reactivation shortly after 1st (four patients) and 2nd dose (three patients) of mRNA COVID-19 vaccines.All four patients who exhibited herpes zoster after the 1st dose of vaccine received the 2nd dose without any adverse reactions or complications. Oral treatment prescribed to all patients with valacyclovir (Valtrex 1 mg tds/day) for 5-7 days led to a complete resolution of symptoms, and rashes disappeared within 9-14 days. Presently, All patients have completed...
Source: Skinmed - August 17, 2022 Category: Dermatology Authors: Alexandra Monastirli Efstathia Pasmatzi George Badavanis Gianna Panagiotopoulou Assimina Apostolidou Dionysios Tsambaos Source Type: research
Herpes Zoster after mRNA COVID-19 Vaccination: A Case Series
We present seven immunocompetent patients devoid of any comorbidities and risk factors, who developed for the first time in their life varicella-zoster virus (VZV) reactivation shortly after 1st (four patients) and 2nd dose (three patients) of mRNA COVID-19 vaccines.All four patients who exhibited herpes zoster after the 1st dose of vaccine received the 2nd dose without any adverse reactions or complications. Oral treatment prescribed to all patients with valacyclovir (Valtrex 1 mg tds/day) for 5-7 days led to a complete resolution of symptoms, and rashes disappeared within 9-14 days. Presently, All patients have completed...
Source: Skinmed - August 17, 2022 Category: Dermatology Authors: Alexandra Monastirli Efstathia Pasmatzi George Badavanis Gianna Panagiotopoulou Assimina Apostolidou Dionysios Tsambaos Source Type: research
Herpes Zoster after mRNA COVID-19 Vaccination: A Case Series
We present seven immunocompetent patients devoid of any comorbidities and risk factors, who developed for the first time in their life varicella-zoster virus (VZV) reactivation shortly after 1st (four patients) and 2nd dose (three patients) of mRNA COVID-19 vaccines.All four patients who exhibited herpes zoster after the 1st dose of vaccine received the 2nd dose without any adverse reactions or complications. Oral treatment prescribed to all patients with valacyclovir (Valtrex 1 mg tds/day) for 5-7 days led to a complete resolution of symptoms, and rashes disappeared within 9-14 days. Presently, All patients have completed...
Source: Skinmed - August 17, 2022 Category: Dermatology Authors: Alexandra Monastirli Efstathia Pasmatzi George Badavanis Gianna Panagiotopoulou Assimina Apostolidou Dionysios Tsambaos Source Type: research
Herpes Zoster after mRNA COVID-19 Vaccination: A Case Series
We present seven immunocompetent patients devoid of any comorbidities and risk factors, who developed for the first time in their life varicella-zoster virus (VZV) reactivation shortly after 1st (four patients) and 2nd dose (three patients) of mRNA COVID-19 vaccines.All four patients who exhibited herpes zoster after the 1st dose of vaccine received the 2nd dose without any adverse reactions or complications. Oral treatment prescribed to all patients with valacyclovir (Valtrex 1 mg tds/day) for 5-7 days led to a complete resolution of symptoms, and rashes disappeared within 9-14 days. Presently, All patients have completed...
Source: Skinmed - August 17, 2022 Category: Dermatology Authors: Alexandra Monastirli Efstathia Pasmatzi George Badavanis Gianna Panagiotopoulou Assimina Apostolidou Dionysios Tsambaos Source Type: research
Herpes Zoster after mRNA COVID-19 Vaccination: A Case Series
We present seven immunocompetent patients devoid of any comorbidities and risk factors, who developed for the first time in their life varicella-zoster virus (VZV) reactivation shortly after 1st (four patients) and 2nd dose (three patients) of mRNA COVID-19 vaccines.All four patients who exhibited herpes zoster after the 1st dose of vaccine received the 2nd dose without any adverse reactions or complications. Oral treatment prescribed to all patients with valacyclovir (Valtrex 1 mg tds/day) for 5-7 days led to a complete resolution of symptoms, and rashes disappeared within 9-14 days. Presently, All patients have completed...
Source: Skinmed - August 17, 2022 Category: Dermatology Authors: Alexandra Monastirli Efstathia Pasmatzi George Badavanis Gianna Panagiotopoulou Assimina Apostolidou Dionysios Tsambaos Source Type: research
Herpes Zoster after mRNA COVID-19 Vaccination: A Case Series
We present seven immunocompetent patients devoid of any comorbidities and risk factors, who developed for the first time in their life varicella-zoster virus (VZV) reactivation shortly after 1st (four patients) and 2nd dose (three patients) of mRNA COVID-19 vaccines.All four patients who exhibited herpes zoster after the 1st dose of vaccine received the 2nd dose without any adverse reactions or complications. Oral treatment prescribed to all patients with valacyclovir (Valtrex 1 mg tds/day) for 5-7 days led to a complete resolution of symptoms, and rashes disappeared within 9-14 days. Presently, All patients have completed...
Source: Skinmed - August 17, 2022 Category: Dermatology Authors: Alexandra Monastirli Efstathia Pasmatzi George Badavanis Gianna Panagiotopoulou Assimina Apostolidou Dionysios Tsambaos Source Type: research
Herpes Zoster after mRNA COVID-19 Vaccination: A Case Series
We present seven immunocompetent patients devoid of any comorbidities and risk factors, who developed for the first time in their life varicella-zoster virus (VZV) reactivation shortly after 1st (four patients) and 2nd dose (three patients) of mRNA COVID-19 vaccines.All four patients who exhibited herpes zoster after the 1st dose of vaccine received the 2nd dose without any adverse reactions or complications. Oral treatment prescribed to all patients with valacyclovir (Valtrex 1 mg tds/day) for 5-7 days led to a complete resolution of symptoms, and rashes disappeared within 9-14 days. Presently, All patients have completed...
Source: Skinmed - August 17, 2022 Category: Dermatology Authors: Alexandra Monastirli Efstathia Pasmatzi George Badavanis Gianna Panagiotopoulou Assimina Apostolidou Dionysios Tsambaos Source Type: research
Herpes Zoster after mRNA COVID-19 Vaccination: A Case Series
We present seven immunocompetent patients devoid of any comorbidities and risk factors, who developed for the first time in their life varicella-zoster virus (VZV) reactivation shortly after 1st (four patients) and 2nd dose (three patients) of mRNA COVID-19 vaccines.All four patients who exhibited herpes zoster after the 1st dose of vaccine received the 2nd dose without any adverse reactions or complications. Oral treatment prescribed to all patients with valacyclovir (Valtrex 1 mg tds/day) for 5-7 days led to a complete resolution of symptoms, and rashes disappeared within 9-14 days. Presently, All patients have completed...
Source: Skinmed - August 17, 2022 Category: Dermatology Authors: Alexandra Monastirli Efstathia Pasmatzi George Badavanis Gianna Panagiotopoulou Assimina Apostolidou Dionysios Tsambaos Source Type: research
Herpes Zoster after mRNA COVID-19 Vaccination: A Case Series
We present seven immunocompetent patients devoid of any comorbidities and risk factors, who developed for the first time in their life varicella-zoster virus (VZV) reactivation shortly after 1st (four patients) and 2nd dose (three patients) of mRNA COVID-19 vaccines.All four patients who exhibited herpes zoster after the 1st dose of vaccine received the 2nd dose without any adverse reactions or complications. Oral treatment prescribed to all patients with valacyclovir (Valtrex 1 mg tds/day) for 5-7 days led to a complete resolution of symptoms, and rashes disappeared within 9-14 days. Presently, All patients have completed...
Source: Skinmed - August 17, 2022 Category: Dermatology Authors: Alexandra Monastirli Efstathia Pasmatzi George Badavanis Gianna Panagiotopoulou Assimina Apostolidou Dionysios Tsambaos Source Type: research
Herpes Zoster after mRNA COVID-19 Vaccination: A Case Series
We present seven immunocompetent patients devoid of any comorbidities and risk factors, who developed for the first time in their life varicella-zoster virus (VZV) reactivation shortly after 1st (four patients) and 2nd dose (three patients) of mRNA COVID-19 vaccines.All four patients who exhibited herpes zoster after the 1st dose of vaccine received the 2nd dose without any adverse reactions or complications. Oral treatment prescribed to all patients with valacyclovir (Valtrex 1 mg tds/day) for 5-7 days led to a complete resolution of symptoms, and rashes disappeared within 9-14 days. Presently, All patients have completed...
Source: Skinmed - August 17, 2022 Category: Dermatology Authors: Alexandra Monastirli Efstathia Pasmatzi George Badavanis Gianna Panagiotopoulou Assimina Apostolidou Dionysios Tsambaos Source Type: research
Novel mutations in antiviral multiresistant HSV-2 genital lesion: a case report
CONCLUSIONS: This report describes a chronic HSV-2 genital lesion, with resistance to current antivirals and novel mutations within viral TK and DNA pol which may confer antiviral resistance. This article is protected by copyright. All rights reserved.PMID:35973907 | DOI:10.1002/jmv.28070 (Source: Herpes)
Source: Herpes - August 16, 2022 Category: Infectious Diseases Authors: Lucas Khellaf Fabrice Bouscarat Sonia Burrel Nadhira Fidouh Lorry Hachon Margot Bucau Sylvie Lariven David Boutolleau V éronique Joly Jade Ghosn Diane Le Pluart Micha ël Thy Source Type: research
Varicella-Zoster Virus Encephalitis in an Immunocompetent Adult with Disseminated Cutaneous Herpes Zoster after Testosterone Booster Supplements: Case Report
We report a 28-year-old male who initially presented to the dermatology clinic with pinprick sensation over the right side of his face that was followed by vesicular eruption. Upon which he was diagnosed with herpes zoster and discharged on topical mupirocin ointment three times a day for 7 days and valacyclovir 1 g oral three times a day. A few hours later, he presented to the emergency department with drowsiness and an episode of loss of consciousness. He was then admitted by neurology and found to have herpetic encephalitis. During admission, he was started on intravenous acyclovir 10 mg/kg three times a day. After 3 we...
Source: Herpes - August 11, 2022 Category: Infectious Diseases Authors: Ghada Alhayaza Abdullah Al-Omair Hind M Almohanna Source Type: research
